Philips Vereos

Description

The Philips Vereos Digital PET/CT System represents a major technological leap by replacing conventional photomultiplier tube (PMT) analog architectures with fully digital photon counting (DPC). Engineered with direct 1:1 coupling between each individual LYSO scintillator crystal and digital silicon detector cell, the system eliminates light-sharing signal degradation. Paired with a high-speed diagnostic CT subsystem (available in 64- or 128-slice configurations), the Vereos provides exceptional spatial resolution, fast acquisition times, and highly reproducible SUV quantitative accuracy for oncology, cardiology, and neurology applications.

Key Features

• Digital Photon Counting (DPC) & 1:1 Coupling: Direct one-to-one coupling of 23,040 LYSO crystals to individual digital silicon photomultiplier (SiPM) detectors maximizes count-rate capability and eliminates analog noise.

• Ultra-Fast Time-of-Flight (TOF) Resolution: ~310 ps timing resolution enhances signal-to-noise ratio (SNR) and image contrast, drastically improving lesion detectability in challenging or large-patient studies.

• High-Performance Multi-Slice CT Subsystem: Configured with 64 or 128 CT channels utilizing 40 mm axial coverage, iDose4 low-dose reconstruction, and optional O-MAR (Orthopedic Metal Artifact Reduction).

• iPatient Workflow & ExamCards: Personalized protocol management and automation software streamline patient preparation and optimize scanning parameters dynamically.

• DoseWise & Smart Radiation Management: Advanced CT dose-modulation tools (Z-DOM, 3D-DOM) and high PET detector sensitivity enable diagnostic quality at significantly reduced tracer and X-ray exposures.

Key Benefits

• Enhanced Small-Lesion Detectability: High spatial resolution (~4.1 mm) and contrast allow radiologists and nuclear medicine physicians to identify subtle primary tumors and micro-metastases with high confidence.

• Reproducible Quantitative Accuracy: Standardized digital SUV quantification (within $\pm 5\%$) supports precise tracking of treatment responses in longitudinal oncology studies.

• Ultra-Fast Scanning Throughput: Superior detector efficiency enables rapid whole-body scans in as little as 2 to 5 minutes, mitigating motion artifacts and boosting daily room capacity.

• Patient Safety & Comfort: Combines low-dose radiotracer injection capabilities with a comfortable, patient-centric gantry design.

• High Operational ROI: Operates as both a digital PET/CT hybrid and a standalone diagnostic CT scanner, maximizing room utilization and long-term equipment value.